Drug and biotech companies join lobbying push on China bill as scrutiny of WuXi continues
Almost 20 biopharma and life sciences companies have registered to lobby on a bill that could ban US companies from working with Chinese life sciences contractors, according to federal records. Since the Biosecure Act was introduced …